Abeona Therapeutics Inc. (ABEO)

Abeona Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 1998
Net Income	-54.19	-43.48	-84.94	-84.23	-76.28	-56.67	-27.32	-21.87	-14.53	-29.65	Upgrade
Depreciation & Amortization	3.2	4.58	4.46	5.6	8.68	2.36	0.74	0.83	0.55	0.01	Upgrade
Share-Based Compensation	4.77	3.05	8.92	8.19	8.24	8.87	5.92	8.26	9.62	1.65	Upgrade
Other Operating Activities	9.21	-11.42	5.89	35.43	-3.45	6.33	-1.99	-0.23	-6.07	23.5	Upgrade
Operating Cash Flow	-37.01	-43.48	-65.67	-35.02	-62.82	-39.11	-22.66	-13.01	-10.42	-1.61	Upgrade
Capital Expenditures	-0.13	1.6	-4.15	-1.34	-6.31	-9.24	-0.86	-0.52	-0.31	0	Upgrade
Acquisitions	0	0	0	0	0	0	0	0	3.7	0	Upgrade
Change in Investments	0.34	-25.57	70.21	-82.38	66.48	-65.59	0	0	0	0	Upgrade
Other Investing Activities	-	-	-	-	-0.2	-10.25	-	-	-	-	Upgrade
Investing Cash Flow	0.21	-23.96	66.06	-83.71	59.98	-85.09	-0.86	-0.52	3.39	0	Upgrade
Share Issuance / Repurchase	37.21	46.96	24.86	0.18	113.9	5.48	92.4	42.54	36.05	12.31	Upgrade
Debt Issued / Paid	-0.15	0	0	1.76	0	0	0	0	-0.4	0.4	Upgrade
Other Financing Activities	-	-3.78	-	-	-	-	-	-	-	-	Upgrade
Financing Cash Flow	37.06	43.17	24.86	1.94	113.9	5.48	92.4	42.54	35.65	12.71	Upgrade
Net Cash Flow	0.26	-24.27	25.26	-116.8	111.06	-118.72	68.89	29	28.62	11.1	Upgrade
Free Cash Flow	-37.14	-41.88	-69.82	-36.36	-69.13	-48.35	-23.52	-13.53	-10.73	-1.61	Upgrade
Free Cash Flow Margin	-1061.03%	-2961.74%	-2327.20%	-363.55%	-	-1612.88%	-2809.44%	-1522.27%	-1031.83%	-174.16%	Upgrade
Free Cash Flow Per Share	-1.74	-5.33	-17.73	-9.81	-34.32	-25.43	-14.12	-9.90	-9.72	-20.73	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).